Market Outlook
The global Embolization Particle market size was valued at USD 2071 million in 2022 and is forecast to a readjusted size of USD 5142.9 million by 2029 with a CAGR of 13.9% during review period.
Embolization Particle or embolization refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report is a detailed and comprehensive analysis for global Embolization Particle market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Embolization Particle market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Embolization Particle market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Embolization Particle market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Embolization Particle market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Embolization Particle
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Embolization Particle market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Segmentation By Type
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segmentation By Application
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Embolization Particle Market in 2025?
The increasing demand for minimally invasive procedures and advancements in medical technologies will fuel the growth of the embolization particle market. Additionally, the rise in the prevalence of cancers and vascular diseases presents a significant market opportunity. The growing acceptance of embolization procedures due to their effectiveness and reduced recovery time is also a key strength.
What weaknesses are present in the Embolization Particle Market in 2025?
The high cost of embolization procedures and particles remains a significant barrier, limiting accessibility for certain patient demographics. There is also a lack of standardized guidelines for embolization treatments, which could hinder widespread adoption. Furthermore, the market faces challenges related to limited product availability in certain regions, particularly in emerging markets.
What opportunities exist in the Embolization Particle Market in 2025?
With the increasing focus on personalized medicine and advanced diagnostic tools, the market has an opportunity to develop more targeted embolization particles. There is also potential for growth in untapped regions, especially in Asia-Pacific, where healthcare infrastructure is rapidly improving. Partnerships and collaborations between medical device companies and healthcare providers can drive innovation and market expansion.
What threats could impact the Embolization Particle Market in 2025?
Intense competition from alternative treatment options, such as surgery and radiation therapy, could pose a threat to the market. Regulatory hurdles, particularly for new products, might slow down the introduction of innovations. Economic downturns could also reduce the demand for elective medical procedures, which might adversely affect the growth of the embolization particle market.
Market PESTEL Analysis
What are the political factors affecting the Embolization Particle Market in 2025?
Government regulations on medical devices and healthcare practices significantly impact the embolization particle market. Political stability in key regions can influence healthcare spending and investments in advanced treatments. Changes in healthcare policies, such as reimbursement rates or funding for medical research, can also either encourage or restrict market growth.
What economic factors could impact the Embolization Particle Market in 2025?
Economic conditions, such as recession or inflation, can affect healthcare budgets and patient spending power. The high cost of embolization procedures might limit their affordability, particularly in developing regions. However, the growing emphasis on cost-effective and minimally invasive procedures may drive demand as hospitals seek to reduce long-term treatment costs.
How do social factors influence the Embolization Particle Market in 2025?
Increasing awareness of health issues like cancer and vascular diseases drives demand for innovative treatments. Patients are becoming more educated about their options, leading to a rise in demand for minimally invasive procedures. Social acceptance of these modern treatments, especially in aging populations, is a significant factor in the market's expansion.
What technological factors are shaping the Embolization Particle Market in 2025?
Advancements in particle design, such as biocompatible and more effective embolization materials, are key to the market's growth. Improved imaging technologies and real-time monitoring systems enhance the precision and safety of embolization procedures. Continued innovation in medical devices and delivery systems is expected to improve treatment outcomes and expand market opportunities.
What environmental factors could affect the Embolization Particle Market in 2025?
Environmental sustainability concerns are prompting manufacturers to focus on eco-friendly materials and production processes. There may also be growing regulations around the disposal of medical waste from embolization procedures. Additionally, natural disasters or pandemics could disrupt global supply chains, affecting product availability and delivery.
What legal factors influence the Embolization Particle Market in 2025?
Strict regulations around the approval and certification of new medical devices, including embolization particles, play a significant role in market dynamics. Laws concerning patient safety and malpractice could influence product development and usage. Additionally, intellectual property laws are crucial for protecting innovations in embolization technology, impacting competition and market entry.
Market SIPOC Analysis
Who are the suppliers in the Embolization Particle Market in 2025?
Suppliers include manufacturers of embolization particles, medical device companies, and raw material suppliers for biocompatible materials. Suppliers of advanced imaging technology and delivery systems also play a key role in the production and delivery of embolization particles.
What are the inputs required for the Embolization Particle Market in 2025?
Inputs include high-quality embolization materials like microspheres, coils, and polymers, as well as advanced technologies for particle production and delivery systems. Additionally, research and development investments, regulatory approvals, and healthcare infrastructure are essential inputs for the market.
What processes are involved in the Embolization Particle Market in 2025?
Key processes include the research and development of new embolization particle technologies, manufacturing of embolization particles, regulatory approval processes, distribution and logistics to healthcare providers, and training for medical professionals to use the embolization products effectively in clinical settings.
Who are the customers in the Embolization Particle Market in 2025?
Customers include hospitals, surgical centers, interventional radiologists, and oncologists who perform embolization procedures. Additionally, healthcare providers such as insurance companies and governmental bodies that reimburse embolization treatments are important stakeholders in the market.
What are the outputs in the Embolization Particle Market in 2025?
Outputs consist of high-quality embolization particles ready for use in medical procedures, including tumor embolization and vascular disease treatments. Other outputs include advanced medical devices for embolization and associated healthcare services such as patient education and post-procedure care.
Market Porter's Five Forces
What is the threat of new entrants in the Embolization Particle Market in 2025?
The threat of new entrants is moderate. While there are high barriers to entry such as regulatory approvals, significant capital investment, and technological expertise, there is potential for innovation, especially with the increasing demand for minimally invasive procedures. New players with cutting-edge technologies or cost-effective solutions could enter the market, but they would need substantial resources to compete with established players.
How intense is the rivalry among existing competitors in the Embolization Particle Market in 2025?
Rivalry among existing competitors is high. The market is driven by a few well-established players with strong technological capabilities, while smaller companies try to carve out niches with innovative or cost-effective products. Competition is intensified by the constant pressure to develop better, more efficient, and safer embolization products to meet growing medical needs.
What is the bargaining power of suppliers in the Embolization Particle Market in 2025?
The bargaining power of suppliers is moderate. While there are specialized suppliers for the raw materials used in embolization particles, the number of suppliers is not overly concentrated, which provides some balance. However, due to the technical nature of the products, suppliers that can provide high-quality materials and advanced technologies have the ability to influence pricing and availability.
What is the bargaining power of buyers in the Embolization Particle Market in 2025?
The bargaining power of buyers is moderate to high. Healthcare providers and institutions, which are the primary buyers, have access to a variety of treatment options. With more awareness and the demand for cost-effective and high-quality solutions, buyers can negotiate better prices and seek products that offer the best clinical outcomes, putting pressure on manufacturers.
What is the threat of substitute products in the Embolization Particle Market in 2025?
The threat of substitutes is moderate. While embolization particles are a critical part of treating certain medical conditions like tumors and vascular diseases, alternative treatments such as surgery, radiation therapy, and other interventional techniques still exist. However, as embolization offers fewer risks and faster recovery times, substitutes are less likely to fully replace this treatment method.
Market Upstream Analysis
What are the key suppliers in the Embolization Particle Market in 2025?
Key suppliers include manufacturers of specialized embolization materials such as microspheres, coils, and biodegradable polymers. Companies that produce raw materials for biocompatible substances and advanced medical device manufacturers that supply delivery systems also play a significant role.
What raw materials are needed for the Embolization Particle Market in 2025?
The raw materials required include biocompatible polymers, cross-linked microspheres, particles made from gelatin, polyvinyl alcohol (PVA), and radiopaque materials. These materials are essential for ensuring the particles perform safely and effectively during embolization procedures.
How are suppliers influencing the Embolization Particle Market in 2025?
Suppliers influence the market through the availability, cost, and quality of raw materials. Innovations in materials, such as more effective and safer embolization particles, can provide competitive advantages. Additionally, suppliers who offer cost-effective solutions and ensure consistent product quality are likely to gain a stronger foothold in the market.
What challenges are faced by suppliers in the Embolization Particle Market in 2025?
Suppliers face challenges related to stringent regulatory requirements for medical products, which can delay production and approval processes. There are also supply chain disruptions, particularly for specialized raw materials, as well as the need for continuous innovation to meet evolving medical needs and patient safety standards.
What opportunities exist for suppliers in the Embolization Particle Market in 2025?
Opportunities include growing demand for advanced embolization materials driven by an increase in minimally invasive procedures and rising prevalence of conditions such as cancer and vascular diseases. Suppliers who can innovate by producing more efficient, cost-effective, and biocompatible materials will likely see significant market growth. There is also potential in expanding into emerging markets where healthcare infrastructure is improving.
Market Midstream Analysis
What are the key players in the Midstream segment of the Embolization Particle Market in 2025?
Key players in the midstream segment include manufacturers and distributors who are responsible for the processing, packaging, and logistics of embolization particles. These companies bridge the gap between raw material suppliers and end-users, including hospitals, surgical centers, and medical practitioners.
How do midstream players add value in the Embolization Particle Market?
Midstream players add value by ensuring the efficient production, packaging, and distribution of embolization particles. They also play a crucial role in ensuring compliance with regulatory standards, providing timely delivery, and maintaining product quality throughout the supply chain.
What are the challenges faced by midstream players in the Embolization Particle Market?
Midstream players face challenges such as fluctuating raw material costs, supply chain disruptions, and the need to meet stringent regulatory requirements for medical devices. Additionally, competition among distributors can impact pricing strategies, and ensuring consistent product availability in various markets can be difficult.
What opportunities are there for midstream players in the Embolization Particle Market in 2025?
Opportunities for midstream players include expanding into emerging markets where the demand for medical procedures is growing. Technological advancements in packaging and distribution can also streamline operations, reduce costs, and increase market penetration. Collaboration with healthcare providers for faster product innovation and distribution could also enhance market share.
How do midstream players influence the Embolization Particle Market?
Midstream players influence the market by ensuring that embolization particles are available when and where they are needed, influencing product access in hospitals and surgical centers. Efficient logistics and distribution networks can also help meet increasing global demand, especially as healthcare infrastructure improves in developing regions.
Market Downstream Analysis
Who are the key players in the Downstream segment of the Embolization Particle Market in 2025?
Key players in the downstream segment include healthcare providers such as hospitals, surgical centers, interventional radiologists, and oncologists who directly use embolization particles in patient treatments. Medical device distributors and insurance companies also play a role in facilitating access to these procedures for patients.
How do downstream players add value in the Embolization Particle Market?
Downstream players add value by directly administering embolization treatments, thereby improving patient outcomes. They ensure the safe and effective use of embolization particles through trained medical professionals. Additionally, they influence the market by adopting and promoting advanced medical technologies and participating in the reimbursement process, which can drive demand for innovative products.
What are the challenges faced by downstream players in the Embolization Particle Market?
Downstream players face challenges such as the high cost of embolization procedures and particle materials, which can limit patient access. There are also complexities related to reimbursement policies and insurance coverage, which vary by region. The need for specialized training for healthcare providers to effectively use these products is another key challenge.
What opportunities are there for downstream players in the Embolization Particle Market in 2025?
Opportunities for downstream players include expanding access to minimally invasive procedures through partnerships with healthcare insurers and increasing patient awareness of treatment options. As the demand for embolization procedures rises with the increasing prevalence of cancers and vascular diseases, downstream players can benefit from adopting more advanced and effective embolization technologies.
How do downstream players influence the Embolization Particle Market?
Downstream players significantly influence the market by driving demand through patient care. Their adoption of new technologies and treatment methodologies can push manufacturers to innovate. Additionally, their role in the reimbursement process and patient access to procedures can shape the market's growth and the adoption rate of new embolization techniques.
Chapter 1, to describe Embolization Particle product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Embolization Particle, with price, sales, revenue and global market share of Embolization Particle from 2018 to 2023.
Chapter 3, the Embolization Particle competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Embolization Particle breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Embolization Particle market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Embolization Particle.
Chapter 14 and 15, to describe Embolization Particle sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Embolization Particle
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Embolization Particle Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Microspheres
1.3.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.3.4 Drug-eluting Beads (DEBs)
1.3.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.4 Market Analysis by Application
1.4.1 Overview: Global Embolization Particle Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Uterine Fibroid Embolization
1.4.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.4.4 Liver Tumor Embolization
1.4.5 Trauma Embolization
1.4.6 Others
1.5 Global Embolization Particle Market Size & Forecast
1.5.1 Global Embolization Particle Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Embolization Particle Sales Quantity (2018-2029)
1.5.3 Global Embolization Particle Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sirtex Medical
2.1.1 Sirtex Medical Details
2.1.2 Sirtex Medical Major Business
2.1.3 Sirtex Medical Embolization Particle Product and Services
2.1.4 Sirtex Medical Embolization Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sirtex Medical Recent Developments/Updates
2.2 Merit Medical
2.2.1 Merit Medical Details
2.2.2 Merit Medical Major Business
2.2.3 Merit Medical Embolization Particle Product and Services
2.2.4 Merit Medical Embolization Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merit Medical Recent Developments/Updates
2.3 Cook Medical
2.3.1 Cook Medical Details
2.3.2 Cook Medical Major Business
2.3.3 Cook Medical Embolization Particle Product and Services
2.3.4 Cook Medical Embolization Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cook Medical Recent Developments/Updates
2.4 BTG Medical
2.4.1 BTG Medical Details
2.4.2 BTG Medical Major Business
2.4.3 BTG Medical Embolization Particle Product and Services
2.4.4 BTG Medical Embolization Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BTG Medical Recent Developments/Updates
2.5 Boston Scientific Corporation
2.5.1 Boston Scientific Corporation Details
2.5.2 Boston Scientific Corporation Major Business
2.5.3 Boston Scientific Corporation Embolization Particle Product and Services
2.5.4 Boston Scientific Corporation Embolization Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Boston Scientific Corporation Recent Developments/Updates
2.6 Terumo Corporation
2.6.1 Terumo Corporation Details
2.6.2 Terumo Corporation Major Business
2.6.3 Terumo Corporation Embolization Particle Product and Services
2.6.4 Terumo Corporation Embolization Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Terumo Corporation Recent Developments/Updates
2.7 HENGRUI Medical
2.7.1 HENGRUI Medical Details
2.7.2 HENGRUI Medical Major Business
2.7.3 HENGRUI Medical Embolization Particle Product and Services
2.7.4 HENGRUI Medical Embolization Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 HENGRUI Medical Recent Developments/Updates
2.8 INterface BIOmaterials B.V.
2.8.1 INterface BIOmaterials B.V. Details
2.8.2 INterface BIOmaterials B.V. Major Business
2.8.3 INterface BIOmaterials B.V. Embolization Particle Product and Services
2.8.4 INterface BIOmaterials B.V. Embolization Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 INterface BIOmaterials B.V. Recent Developments/Updates
2.9 Alicon
2.9.1 Alicon Details
2.9.2 Alicon Major Business
2.9.3 Alicon Embolization Particle Product and Services
2.9.4 Alicon Embolization Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Alicon Recent Developments/Updates
3 Competitive Environment: Embolization Particle by Manufacturer
3.1 Global Embolization Particle Sales Quantity by Manufacturer (2018-2023)
3.2 Global Embolization Particle Revenue by Manufacturer (2018-2023)
3.3 Global Embolization Particle Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Embolization Particle by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Embolization Particle Manufacturer Market Share in 2022
3.4.2 Top 6 Embolization Particle Manufacturer Market Share in 2022
3.5 Embolization Particle Market: Overall Company Footprint Analysis
3.5.1 Embolization Particle Market: Region Footprint
3.5.2 Embolization Particle Market: Company Product Type Footprint
3.5.3 Embolization Particle Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Embolization Particle Market Size by Region
4.1.1 Global Embolization Particle Sales Quantity by Region (2018-2029)
4.1.2 Global Embolization Particle Consumption Value by Region (2018-2029)
4.1.3 Global Embolization Particle Average Price by Region (2018-2029)
4.2 North America Embolization Particle Consumption Value (2018-2029)
4.3 Europe Embolization Particle Consumption Value (2018-2029)
4.4 Asia-Pacific Embolization Particle Consumption Value (2018-2029)
4.5 South America Embolization Particle Consumption Value (2018-2029)
4.6 Middle East and Africa Embolization Particle Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Embolization Particle Sales Quantity by Type (2018-2029)
5.2 Global Embolization Particle Consumption Value by Type (2018-2029)
5.3 Global Embolization Particle Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Embolization Particle Sales Quantity by Application (2018-2029)
6.2 Global Embolization Particle Consumption Value by Application (2018-2029)
6.3 Global Embolization Particle Average Price by Application (2018-2029)
7 North America
7.1 North America Embolization Particle Sales Quantity by Type (2018-2029)
7.2 North America Embolization Particle Sales Quantity by Application (2018-2029)
7.3 North America Embolization Particle Market Size by Country
7.3.1 North America Embolization Particle Sales Quantity by Country (2018-2029)
7.3.2 North America Embolization Particle Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Embolization Particle Sales Quantity by Type (2018-2029)
8.2 Europe Embolization Particle Sales Quantity by Application (2018-2029)
8.3 Europe Embolization Particle Market Size by Country
8.3.1 Europe Embolization Particle Sales Quantity by Country (2018-2029)
8.3.2 Europe Embolization Particle Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Embolization Particle Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Embolization Particle Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Embolization Particle Market Size by Region
9.3.1 Asia-Pacific Embolization Particle Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Embolization Particle Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Embolization Particle Sales Quantity by Type (2018-2029)
10.2 South America Embolization Particle Sales Quantity by Application (2018-2029)
10.3 South America Embolization Particle Market Size by Country
10.3.1 South America Embolization Particle Sales Quantity by Country (2018-2029)
10.3.2 South America Embolization Particle Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Embolization Particle Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Embolization Particle Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Embolization Particle Market Size by Country
11.3.1 Middle East & Africa Embolization Particle Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Embolization Particle Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Embolization Particle Market Drivers
12.2 Embolization Particle Market Restraints
12.3 Embolization Particle Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Embolization Particle and Key Manufacturers
13.2 Manufacturing Costs Percentage of Embolization Particle
13.3 Embolization Particle Production Process
13.4 Embolization Particle Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Embolization Particle Typical Distributors
14.3 Embolization Particle Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Embolization Particle Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Embolization Particle Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sirtex Medical Basic Information, Manufacturing Base and Competitors
Table 4. Sirtex Medical Major Business
Table 5. Sirtex Medical Embolization Particle Product and Services
Table 6. Sirtex Medical Embolization Particle Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sirtex Medical Recent Developments/Updates
Table 8. Merit Medical Basic Information, Manufacturing Base and Competitors
Table 9. Merit Medical Major Business
Table 10. Merit Medical Embolization Particle Product and Services
Table 11. Merit Medical Embolization Particle Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merit Medical Recent Developments/Updates
Table 13. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 14. Cook Medical Major Business
Table 15. Cook Medical Embolization Particle Product and Services
Table 16. Cook Medical Embolization Particle Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Cook Medical Recent Developments/Updates
Table 18. BTG Medical Basic Information, Manufacturing Base and Competitors
Table 19. BTG Medical Major Business
Table 20. BTG Medical Embolization Particle Product and Services
Table 21. BTG Medical Embolization Particle Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BTG Medical Recent Developments/Updates
Table 23. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Boston Scientific Corporation Major Business
Table 25. Boston Scientific Corporation Embolization Particle Product and Services
Table 26. Boston Scientific Corporation Embolization Particle Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Boston Scientific Corporation Recent Developments/Updates
Table 28. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 29. Terumo Corporation Major Business
Table 30. Terumo Corporation Embolization Particle Product and Services
Table 31. Terumo Corporation Embolization Particle Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Terumo Corporation Recent Developments/Updates
Table 33. HENGRUI Medical Basic Information, Manufacturing Base and Competitors
Table 34. HENGRUI Medical Major Business
Table 35. HENGRUI Medical Embolization Particle Product and Services
Table 36. HENGRUI Medical Embolization Particle Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. HENGRUI Medical Recent Developments/Updates
Table 38. INterface BIOmaterials B.V. Basic Information, Manufacturing Base and Competitors
Table 39. INterface BIOmaterials B.V. Major Business
Table 40. INterface BIOmaterials B.V. Embolization Particle Product and Services
Table 41. INterface BIOmaterials B.V. Embolization Particle Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. INterface BIOmaterials B.V. Recent Developments/Updates
Table 43. Alicon Basic Information, Manufacturing Base and Competitors
Table 44. Alicon Major Business
Table 45. Alicon Embolization Particle Product and Services
Table 46. Alicon Embolization Particle Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Alicon Recent Developments/Updates
Table 48. Global Embolization Particle Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Embolization Particle Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Embolization Particle Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 51. Market Position of Manufacturers in Embolization Particle, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Embolization Particle Production Site of Key Manufacturer
Table 53. Embolization Particle Market: Company Product Type Footprint
Table 54. Embolization Particle Market: Company Product Application Footprint
Table 55. Embolization Particle New Market Entrants and Barriers to Market Entry
Table 56. Embolization Particle Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Embolization Particle Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Embolization Particle Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Embolization Particle Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Embolization Particle Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Embolization Particle Average Price by Region (2018-2023) & (USD/Unit)
Table 62. Global Embolization Particle Average Price by Region (2024-2029) & (USD/Unit)
Table 63. Global Embolization Particle Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Embolization Particle Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Embolization Particle Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Embolization Particle Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Embolization Particle Average Price by Type (2018-2023) & (USD/Unit)
Table 68. Global Embolization Particle Average Price by Type (2024-2029) & (USD/Unit)
Table 69. Global Embolization Particle Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Embolization Particle Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Embolization Particle Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Embolization Particle Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Embolization Particle Average Price by Application (2018-2023) & (USD/Unit)
Table 74. Global Embolization Particle Average Price by Application (2024-2029) & (USD/Unit)
Table 75. North America Embolization Particle Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Embolization Particle Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Embolization Particle Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Embolization Particle Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Embolization Particle Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Embolization Particle Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Embolization Particle Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Embolization Particle Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Embolization Particle Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Embolization Particle Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Embolization Particle Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Embolization Particle Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Embolization Particle Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Embolization Particle Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Embolization Particle Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Embolization Particle Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Embolization Particle Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Embolization Particle Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Embolization Particle Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Embolization Particle Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Embolization Particle Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Embolization Particle Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Embolization Particle Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Embolization Particle Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Embolization Particle Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Embolization Particle Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Embolization Particle Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Embolization Particle Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Embolization Particle Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Embolization Particle Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Embolization Particle Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Embolization Particle Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Embolization Particle Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Embolization Particle Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Embolization Particle Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Embolization Particle Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Embolization Particle Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Embolization Particle Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Embolization Particle Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Embolization Particle Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Embolization Particle Raw Material
Table 116. Key Manufacturers of Embolization Particle Raw Materials
Table 117. Embolization Particle Typical Distributors
Table 118. Embolization Particle Typical Customers
List of Figures
Figure 1. Embolization Particle Picture
Figure 2. Global Embolization Particle Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Embolization Particle Consumption Value Market Share by Type in 2022
Figure 4. Microspheres Examples
Figure 5. Particles (e.g. PVA Particles, Gelfoam Particles) Examples
Figure 6. Drug-eluting Beads (DEBs) Examples
Figure 7. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Examples
Figure 8. Global Embolization Particle Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Embolization Particle Consumption Value Market Share by Application in 2022
Figure 10. Uterine Fibroid Embolization Examples
Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Examples
Figure 12. Liver Tumor Embolization Examples
Figure 13. Trauma Embolization Examples
Figure 14. Others Examples
Figure 15. Global Embolization Particle Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Embolization Particle Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Embolization Particle Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Embolization Particle Average Price (2018-2029) & (USD/Unit)
Figure 19. Global Embolization Particle Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Embolization Particle Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Embolization Particle by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Embolization Particle Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Embolization Particle Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Embolization Particle Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Embolization Particle Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Embolization Particle Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Embolization Particle Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Embolization Particle Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Embolization Particle Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Embolization Particle Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Embolization Particle Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Embolization Particle Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Embolization Particle Average Price by Type (2018-2029) & (USD/Unit)
Figure 34. Global Embolization Particle Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Embolization Particle Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Embolization Particle Average Price by Application (2018-2029) & (USD/Unit)
Figure 37. North America Embolization Particle Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Embolization Particle Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Embolization Particle Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Embolization Particle Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Embolization Particle Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Embolization Particle Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Embolization Particle Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Embolization Particle Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Embolization Particle Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Embolization Particle Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Embolization Particle Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Embolization Particle Consumption Value Market Share by Region (2018-2029)
Figure 57. China Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Embolization Particle Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Embolization Particle Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Embolization Particle Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Embolization Particle Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Embolization Particle Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Embolization Particle Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Embolization Particle Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Embolization Particle Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Embolization Particle Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Embolization Particle Market Drivers
Figure 78. Embolization Particle Market Restraints
Figure 79. Embolization Particle Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Embolization Particle in 2022
Figure 82. Manufacturing Process Analysis of Embolization Particle
Figure 83. Embolization Particle Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
